Mercaptopurine (also called 6-Mercaptopurine, 6-MP or its brand name Purinethol®) is an immunosuppressive drug used to treat leukemia. It is also used for pediatric non-Hodgkin's lymphoma, polycythemia vera, and psoriatic arthritis. It may also be used to treat inflammatory bowel disease (such as Crohn's Disease and ulcerative colitis).
Adverse reactions
Some of the adverse reactions of taking Mercaptopurine might include diarrhea, nausea, vomiting, loss of appetite, stomach/abdominal pain, weakness, skin rash, darkening of the skin, or hair loss. Serious adverse reactions include mouth sores, fever, sore throat, easy bruising or bleeding, pinpoint red spots on the skin, yellowing of eyes or skin, dark urine, painful or difficult urination. Unlikely but serious side effects include: black or tarry stools (melena), bloody stools, and bloody urine.
More on
[ Mercaptopurine ]
Mercaptopurine - Twitter Searchcombo chemothrpy w/ or w/o gemtuzumab followed by tretinoin, mercaptopurine, & methotex8 or observation in treating ppl http://bit.ly/8ilPSVlocaltrials (US Clinical Trials ) Sat, 05 Dec 2009 03:34:53 -0000
combo chemothrpy w/ or w/o gemtuzumab followed by tretinoin, mercaptopurine, & methotex8 or observation in treating ppl http://bit.ly/8ilPSV
combo chemothrpy w/ or w/o gemtuzumab followed by tretinoin, mercaptopurine, & methotex8 or observation in treating ppl http://bit.ly/8ilPSVusclinicaltrial (US Clinical Trials) Sat, 05 Dec 2009 03:26:50 -0000
combo chemothrpy w/ or w/o gemtuzumab followed by tretinoin, mercaptopurine, & methotex8 or observation in treating ppl http://bit.ly/8ilPSV
combo chemothrpy w/ or w/o gemtuzumab followed by tretinoin, mercaptopurine, & methotex8 or observation in treating ppl http://bit.ly/8ilPSVrecruitingtrial (Recruiting Trials) Sat, 05 Dec 2009 01:52:27 -0000
combo chemothrpy w/ or w/o gemtuzumab followed by tretinoin, mercaptopurine, & methotex8 or observation in treating ppl http://bit.ly/8ilPSV
Subscribe to Mercaptopurine RSS feed 
Mercaptopurine - Familydoctor.org - Information for patients in English and Spanish.